Expression of S100 protein family members in normal skin and sweat gland tumors

Journal of Dermatological Science

Volumn 70, Issue 3, 2013, Pages 211-219

  Zhu, Li ^a,b   Okano, Shinji ^a   Takahara, Masakazu ^a   Chiba, Takahito ^a   Tu, Yating ^b   Oda, Yoshinao ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ca2+ binding S100 proteins; Skin immunohistochemistry; Sweat gland tumors

Indexed keywords

CALGRANULIN A; CALVASCULIN; PROTEIN ANTIBODY; PROTEIN S 100; PROTEIN S 100A11; PROTEIN S 100A11 ANTIBODY; PROTEIN S 100A2; PROTEIN S 100A2 ANTIBODY; PROTEIN S 100A4 ANTIBODY; PROTEIN S 100A6; PROTEIN S 100A6 ANTIBODY; PROTEIN S 100A7 ANTIBODY; PROTEIN S 100A8 ANTIBODY; PROTEIN S 100A9; PROTEIN S 100A9 ANTIBODY; PROTEIN S 100P; PROTEIN S 100P ANTIBODY; PSORIASIN; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ANTIGEN BINDING; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA METHYLATION; HIDRADENOMA; HUMAN; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; LANGERHANS CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN SECRETION; SKIN; SWEAT GLAND; SWEAT GLAND TUMOR; SYRINGOMA;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; PREDICTIVE VALUE OF TESTS; S100 PROTEINS; SKIN; SWEAT GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878136929     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.03.002     Document Type: Article

References (41)

1. Fritz G., Botelho H.M., Morozova-Roche L.A., Gomes C.M. Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity. FEBS J 2010, 277(22):4578-4590.
2. Mishra S.K., Siddique H.R., Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev 2012, 31(1-2):163-172.
3. van Dieck J., Fernandez-Fernandez M.R., Veprintsev D.B., Fersht A.R. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J Biol Chem 2009, 284:13804-13811.
4. Yao R., Lopez-Beltran A., Maclennan G.T., Montironi R., Eble J.N., Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 2007, 27(5A):3051-3058.
5. Salama I., Malone P.S., Mihaimeed F., Jones J.L. A review of the S100 proteins in cancer. Eur J Surg Oncol 2008, 34:357-364.
6. Lukanidin E., Sleeman J.P. Building the niche: the role of the S100 proteins in metastatic growth. Semin Cancer Biol 2012, 22(3):216-225.
7. Li Y., Liu Z.L., Zhang K.L., Chen X.Y., Kong Q.Y., Wu M.L., et al. Methylation-associated silencing of S100A4 expression in human epidermal cancers. Exp Dermatol 2009, 18(10):842-848.
8. Fullen D.R., Reed J.A., Finnerty B., McNutt N.S. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays. J Cutan Pathol 2008, 35(Suppl. 2):28-34.
9. Eckert R.L., Broome A.M., Ruse M., Robinson N., Ryan D., Lee K. S100 proteins in the epidermis. J Invest Dermatol 2004, 123(1):23-33.
10. Kizawa K., Toyoda M., Ito M., Morohashi M. Aberrantly differentiated cells in benign pilomatrixoma reflect the normal hair follicle: immunohistochemical analysis of Ca-binding S100A2, S100A3 and S100A6 proteins. Br J Dermatol 2005, 152(2):314-320.
11. Eckert R.L., Lee K.C. S100A7 (psoriasin): a story of mice and men. J Invest Dermatol 2006, 126(7):1442-1444.
12. Zibert J.R., Skov L., Thyssen J.P., Jacobsen G.K., Grigorian M. Significance of the S100A4 protein in psoriasis. J Invest Dermatol 2010, 130(1):150-160.
13. Emelianov V.U., Bechara F.G., Gläser R., Langan E.A., Taungjaruwinai W.M., Schröder J.M., et al. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. Br J Dermatol 2012, 166(5):1023-1034.
14. 2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol 1997, 137(July (1)):39-43.
15. Shrestha P., Muramatsu Y., Kudeken W., Mori M., Takai Y., Ilg E.C., et al. Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin. Virchows Arch 1998, 432(January (1)):53-59.
16. Langbein L., Rogers M.A., Praetzel S., Cribier B., Peltre B., Gassler N., et al. Characterization of a novel human type II epithelial keratin K1b, specifically expressed in eccrine sweat glands. J Invest Dermatol 2005, 125(3):428-444.
17. Santamaria-Kisiel L., Rintala-Dempsey A.C., Shaw G.S. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 2006, 396:201-214.
18. Botelho H.M., Fritz G., Gomes C.M. Analysis of S100 oligomers and amyloids. Methods Mol Biol 2012, 849:373-386.
19. Lee K., Yun S.T., Yun C.O., Ahn B.Y., Jo E.C. S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma. Gene Ther 2012, 19(10):967-977.
20. Chai J., Jamal M.M. S100A4 in esophageal cancer: is this the one to blame?. World J Gastroenterol 2012, 18(30):3931-3935.
21. Kilańczyk E., Graczyk A., Ostrowska H., Kasacka I., LeŚniak W., Filipek A. S100A6 is transcriptionally regulated by β-catenin and interacts with a novel target, lamin A/C, in colorectal cancer cells. Cell Calcium 2012, 51(6):470-477.
22. Ning X., Sun S., Zhang K., Liang J., Chuai Y., Li Y., et al. S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis. PLoS ONE 2012, 7(1):e30185.
23. Yang X., Wei K.J., Zhang L., Pan H.Y., Ye D.X., Zhong L.P., et al. Decreased expression of S100A6 in oral squamous cell carcinoma. Oncol Rep 2010, 24(2):479-488.
24. Winston J., Wolf R. Psoriasin (S100A7) promotes migration of a squamous carcinoma cell line. J Dermatol Sci 2012, 67(3):205-207.
25. Nasser M.W., Qamri Z., Deol Y.S., Ravi J., Powell C.A., Trikha P., et al. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res 2012, 72(3):604-615.
26. Srikrishna G. S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun 2012, 4(1):31-40.
27. Grebhardt S., Veltkamp C., Ströbel P., Mayer D. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer. Int J Cancer 2012, 131(12):2785-2794.
28. Memon A.A., Sorensen B.S., Meldgaard P., Fokdal L., Thykjaer T., Nexo E. Down-regulation of S100C is associated with bladder cancer progression and poor survival. Clin Cancer Res 2005, 11(2 Pt 1):606-611.
29. 2+-binding protein S100A11: a novel diagnostic marker for breast carcinoma. Oncol Rep 2010, 23(5):1301-1308.
30. Aishima S., Fujita N., Mano Y., Kubo Y., Tanaka Y., Taketomi A., et al. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg Pathol 2011, 35:590-598.
31. Hashimoto K., Yamamoto H., Shiratsuchi H., Nakashima T., Tamiya S., Higaki Y., et al. S100P expression in ductal type of carcinoma ex pleomorphic adenoma. Am J Surg Pathol 2011, 35:346-355.
32. Shiota M., Tsunoda T., Song Y., Yokomizo A., Tada Y., Oda Y., et al. Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin. BJU Int 2011, 107:1148-1153.
33. Jiang H., Hu H., Tong X., Jiang Q., Zhu H., Zhang S. Calcium-binding protein S100P and cancer: mechanisms and clinical relevance. J Cancer Res Clin Oncol 2012, 138(1):1-9.
34. Zhang T., Woods T.L., Elder J.T. Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized, and malignant human keratinocytes. J Invest Dermatol 2002 Nov, 119(5):1196-1201.
35. Boomershine C.S., Chamberlain A., Kendall P., Afshar-Sharif A.R., Huang H., Washington M.K., et al. Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells. Gut 2009, 58:1267-1274.
36. Petersson S., Shubbar E., Enerbäck L., Enerbäck C. Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Melanoma Res 2009, 19:215-225.
37. Mori M., Yamada K., Ohomura H., Wataru K., Takai Y., Ilg E., et al. Immunohistochemical localization of S100A1 and S100A6 in postnatally developing salivary glands of rats. Histochem Cell Biol 1998, 110(6):579-587.
38. Wolk K., Witte E., Wallace E., Döcke W.D., Kunz S., Asadullah K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006, 36:1309-1323.
39. Reithmayer K., Meyer K.C., Kleditzsch P., Tiede S., Uppalapati S.K., Glaser R., et al. Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. Br J Dermatol 2009, 161(1):78-89.
40. Garreis F., Gottschalt M., Schlorf T., Gläser R., Harder J., Worlitzsch D., et al. Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus. Invest Ophthalmol Vis Sci 2011, 52:4914-4922.
41. Hegyi Z., Zwicker S., Bureik D., Peric M., Koglin S., Batycka-Baran A., et al. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J Invest Dermatol 2012, 132:1416-1424.